Epidemiology of DSM-5 bipolar I disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions – III

Journal of Psychiatric Research

Volumn 84, Issue , 2017, Pages 310-317

  Blanco, Carlos ^a   Compton, Wilson M ^a   Saha, Tulshi D ^b   Goldstein, Benjamin I ^c   Ruan, W June ^b   Huang, Boji ^b   Grant, Bridget F ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Bipolar I disorder; Comorbidity; Epidemiology; Prevalence; Treatment

Indexed keywords

ADULT; AGED; AMERICAN INDIAN; ANXIETY DISORDER; ARTICLE; BIPOLAR I DISORDER; BLACK PERSON; COMORBIDITY; DISABILITY; DRUG DEPENDENCE; DSM-5; EDUCATIONAL STATUS; FAMILY INCOME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PACIFIC ISLANDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOTYPAL PERSONALITY DISORDER; ADOLESCENT; AGE; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MIDDLE AGED; PSYCHOLOGICAL INTERVIEW; PSYCHOLOGY; SEX DIFFERENCE; SOCIOECONOMICS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BIPOLAR DISORDER; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISABILITY EVALUATION; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; SEX FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84994316460     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2016.10.003     Document Type: Article

References (81)

1. Alegria, M., Canino, G., Stinson, F.S., et al. Nativity and DSM-IV psychiatric disorders among puerto ricans, cuban Americans, and non-latino whites in the United States: results from the national epidemiologic survey on alcohol and related conditions. J. Clin. Psychiatry 67:1 (2006), 56–65.
2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. fifth ed., 2013, American Psychiatric Association, Arlington, VA.
3. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. fourth ed., 1994, American Psychiatric Association, Washington, DC.
4. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 3rd, 1987, American Psychiatric Association, Washington, DC Revised.
5. Angst, J., Dobler-Mikola, A., Binder, J., The Zurich study—a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. I. problem, methodology. Eur. Arch. Psychiatry Neurol. Sci. 234:1 (1984), 13–20.
6. Barry, C.L., Huskamp, H.A., Moving beyond parity – mental health and addiction care under the ACA. N. Engl. J. Med. 365:11 (2011), 973–975.
7. Bassett, D., Borderline personality disorder and bipolar affective disorder. Spectra or spectre? A review. Aust. N. Z. J. Psychiatry 46:4 (2012), 327–339.
8. Beaulieu, S., Saury, S., Sareen, J., et al. The Canadian Network Mood and Anxiety Treatments (CANMAT) Task Force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann. Clin. Psychiatry 24:1 (2012), 38–55.
9. Blanco, C., Morcillo, C., Alegria, M., et al. Acculturation and drug use disorders among Hispanics in the U.S. J. Psychiatry Res. 47:2 (2013), 226–232.
10. Brietzke, E., Mansur, R.B., Soczynska, J.K., et al. Towards a multifactorial approach for prediction of bipolar disorder in at risk populations. J. Affect. Disord. 140:1 (2012), 82–91.
11. Bureau of the Census, American Community Survey, 2012. 2013, Bureau of the Census, Suitland, MD.
12. Carvalho, A.F., Takwoingi, Y., Sales, P.M.G., et al. Screening for bipolar spectrum disorders: a comprehensive meta-analysis of accuracy studies. J. Affect. Disord. 17:2 (2015), 337–346.
13. Centers for Disease Control and Prevention, Fatal Injury Report, 2000-2013., 2014, Centers for Disease Control and Prevention, Atlanta, GA.
14. Centers for Disease Control and Prevention, Unweighted Response Rates for the NHANES 2011-2012. 2013, Center for Disease Control and Prevention, Atlanta, GA.
15. Cerimele, J.M., Chwastiak, L.A., Dodson, S., Katon, W.J., The prevalence of bipolar disorder in general primary care samples: a systematic review. Gen. Hosp. Psychiatry 36:1 (2014), 19–25.
16. Chen, C.N., Wong, J., Lee, N., et al. The Shatin community mental health survey in Hong Kong. II. Major findings. Arch. Gen. Psychiatry 50:2 (1993), 125–133.
17. Clemente, A.S., Kiniz, B.S., Nicolato, R., et al. Bipolar disorder prevalence: a systematic review and meta-analysis of the literature. Rev. Bras. pisq 37:3 (2015), 155–161.
18. Craddock, N., Sklar, P., Genetics of bipolar disorder. Lancet 381:9878 (2013), 1654–1662.
19. Crump, C., Sundquist, K., Winkleby, M.D., et al. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry 70:9 (2013), 931–939.
20. da Silva Costa, L., Alencar, A.P., Neto, P.J.N., et al. Risk factors for suicide in bipolar disorder: a systematic review. J. Aff. Disord. 170:3 (2015), 237–254.
21. Dawson, D.A., Goldstein, R.B., Saha, T.D., Grant, B.F., Changes in alcohol consumption: United States, 2001-2002 to 2012-2013. Drug alc. Depend. 148:1 (2015), 56–61.
22. Dell'Aglio, J.C., Basso, L.A., de Lima Argimon, I.I., Artehe, A., Systematic review of the prevalence of bipolar disorder and bipolar spectrum disorders in population-based studies. Trends Psychiatry Psychother. 35:2 (2013), 99–105.
23. Di Florio, A., Craddock, N., van den Bree, M., Alcohol misuse in bipolar disorder: a systematic review and meta-analysis of comorbidity rates. Euro. Psychiatry 29:2 (2014), 117–124.
24. Dilsaver, S.C., An estimate of the minimum economic burden of bipolar I and II disorders in the United States. J. Affect. Disord. 129:1–3 (2011), 79–83.
25. Fan, A.H., Hassell, J., Bipolar disorder and comorbid personality psychopathology: a review of the literature. J. Clin. Psychiatry 69:11 (2008), 1794–1803.
26. Faravelli, C., Guerrini Degl'Innocenti, B., Aiazzi, L., et al. Epidemiology of mood disorders: a community survey in Florence. J. Affect. Disord. 20:2 (1990), 135–141.
27. Gadermann, A.M., Alonso, J., Vilagut, G., Zaslavsky, A.M., Kessler, R.C., Comorbidity and disease burden in the national comorbidity survey replication (NCS-R). Depress. Anxiety 29:9 (2012), 797–806.
28. Gandek, B., Ware, J.E., Aaronson, N.K., et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. J. Clin. Epidemiol. 51:11 (1998), 1149–1158.
29. Garno, J.L., Goldberg, J.F., Ramirez, P.M., et al. Bipolar disorder with comorbid cluster B personality disorder features: impact on suicidality. J. Clin. Psychiatry 66:3 (2005), 339–345.
30. Geddes, J.R., Miklowitz, D.J., Treatment of bipolar disorder. Lancet 381:9878 (2013), 1672–1682.
31. Gibbs, T., Okuda, M., Oquendo, M.A., et al. Mental health of African Americans and caribbean Blacks in the United States: results from the national epidemiological survey on alcohol and related conditions. Am. J. Public Health 103:2 (2013), 330–338.
32. Goldstein, B.I., Recent progress in understanding pediatric bipolar disorder. Arch. Pediatr. Adolesc. Med. 166:4 (2012), 362–371.
33. Goldstein, B.I., Schaffer, A., Wang, S., et al. Excessive and premature new-onset cardiovascular disease among adults with bipolar disorder in the US NESARC Cohort. J. Clin. Psychiatry 76:2 (2015), 163–169.
34. Gone, J.P., Trimble, J.E., American Indian and Alaska Native mental health: diverse perspectives on enduring disparities. Annu. Rev. Clin. Psychol. 8 (2012), 131–160.
35. Grant, B.F., Ansbary, M., Chu, A., et al. Source and Accuracy Statement: National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). 2014, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
36. Grant, B.F., Chou, S.P., Goldstein, R.B., et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personal disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions. J. Clin. Psychiatry 69:4 (2008), 533–545.
37. Grant, B.F., Goldstein, R.B., Chou, S.P., The Alcohol Use Disorder and Associated Disabilities Interview Schedule – Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Version (AUDADIS-5). 2011, National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
38. Grant, B.F., Goldstein, R.B., Saha, T.D., et al. Epidemiology of DSM-5 alcohol Use disorder: results from the national epidemiologic survey on alcohol and related conditions-III. JAMA Psychiatry 72:8 (2015), 757–766.
39. Grant, B.F., Saha, T.D., Ruan, W.J., et al. Epidemiology of DSM-5 drug use disorder: results from the national epidemiologic survey on alcohol and related conditions-III. JAMA Psychiatry 72:8 (2015), 1–9.
40. Grant, B.F., Stinson, F.S., Hasin, D.S., et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the national epidemiologic survey on alcohol and related conditions. J. Clin. Psychiatry 66:10 (2005), 1205–1215.
41. Hasin, D.S., Aivadyan, C., Greenstein, E., et al. Psychiatric Research Interview for Substance Use and Mental Disorders, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (PRISM-5) Version. 2011, Columbia University, Department of Psychiatry, 2011, New York, NY.
42. Hasin, D.S., Greenstein, E., Aivadyan, C., et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug Alcohol Depend. 148:1 (2015), 40–46.
43. Hasin, D.S., Shmulewitz, D., Stohl, M., et al. Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: substance abusers and others in the general population. Drug Alcohol Depend. 152 (2015), 246–256.
44. Hawke, L.D., Parikh, S.V., Michalak, E.E., Stigma and bipolar disorder: a review of the literature. J. Affect. Disord. 15:2 (2013), 181–191.
45. Hoertel, N., Franco, S., Wall, M.M., et al. Mental disorders and risk of suicide attempt: a national prospective study. Mol. Psychiatry 20:6 (2015), 718–726.
46. Judd, L.L., Akiskal, H.S., Schettier, P.J., et al. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch. Gen. Psychiatry 62:2 (2005), 1322–1330.
47. Keck, P.E., Kessler, R.C., Ross, R., Clinical and economic effects of unrecognized or inadequately treated bipolar disorder. J. Psych. Pract. 14:2 (2006), 31–38.
48. Kessler, R.C., Merikangas, K.R., Wang, P.S., Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu. Rev. Clin. Psychol. 3 (2007), 137–158.
49. Ketter, T.A., Advances in Treatment of Bipolar Disorders. 2015, American Psychiatric Publishing, Washington DC.
50. Ketter, T.A., Handbook of Diagnosis and Treatment of Bipolar Disorders. 2010, American Psychiatric Publishing, Washington DC.
51. Latalova, K., Ociskova, M., Prasko, J., et al. Self-stigmatization in patients with bipolar disorder. Neuro. Engocrinol. Lett. 34:4 (2013), 265–372.
52. Marangell, L.B., Bauer, M.S., Dennehy, E.B., et al. Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years. Bipolar Disord. 8:5 Pt 2 (2006), 566–575.
53. McDermid, J., Sareen, J., El-Gabalawy, R., et al. Co-morbidity of bipolar disorder and borderline personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Compr. Psychiatry 58:1 (2015), 18–28.
54. Merikangas, K.R., Akiskal, H.S., Angst, J., et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch. Gen. Psychiatry 64:5 (2007), 543–552.
55. Merikangas, K.R., Jin, R., He, J.P., et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch. Gen. Psychiatry 68:3 (2011), 241–251.
56. Moreno, C., Hasin, D.S., Arango, C., et al. Depression in bipolar versus major depressive disorder: results from the national epidemiologic survey on alcohol and related conditions. Bipolar Disord. 14:3 (2012), 271–282.
57. Oquendo, M.A., Currier, D., Liu, S., et al. Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders. J. Clin. Psychiatry 71:7 (2010), 902–909.
58. Paris, J., Gunderson, J., Weinberg, I., The interface between borderline personality disorder and bipolar spectrum disorders. Compr. Psychiatry 48:2 (2007), 145–154.
59. Phillips, M.L., Kupfer, D.J., Bipolar disorder diagnosis: challenges and future directions. Lancet 381:9878 (2013), 1663–1671.
60. Research Triangle Institute, SUDAAN Language Manual, Release 11.0. 2012, Research Triangle Institute, Research Triangle Park, NC.
61. Rosa, A.R., Reinares, M., Michalak, E.E., et al. Functional impairment and disability across mood states in bipolar disorder. Val. Health 13:8 (2010), 984–988.
62. Rosenbluth, M., MacQueen, G., McIntyre, R.S., et al. The Canadian Network Mood and Anxiety Treatments (CANMAT) Task Force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann. Clin. Psychiatry 24:1 (2012), 56–68.
63. Roshanaei-Moghaddam, B., Katon, W., Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatry Serv. 60:2 (2009), 147–156.
64. Rubio, J.M., Olfson, M., Perez-Fuentes, G., et al. Effect of first episode Axis I disorders on quality of life. J. Nerv. Ment. Dis. 202:4 (2014), 271–274.
65. Rubio, J.M., Olfson, M., Villegas, L., et al. Quality of life following remission of mental disorders: findings from the national epidemiologic survey on alcohol and related conditions. J. Clin. Psychiatry 74:5 (2013), E445–E450.
66. Ruggero, C.J., Zimmerman, M., Chelminski, I., et al. Borderline personality disorder and the misdiagnosis of bipolar disorder. J. Psychiatr. Res. 44:6 (2010), 405–408.
67. Sala, R., Goldstein, B., Wang, S., et al. Childhood maltreatment and the course of bipolar disorders among adults: epidemiologic evidence of dose-response effects. J. Affect. Disord. 165 (2014), 74–80.
68. Schaffer, A., Isometsa, E.T., Azorin, J.M., et al. A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust. N. Z. J. Psychiatry 49:1 (2015), 1006–1020.
69. Simon, G.E., Bauer, M.S., Ludman, E.J., Operskalski, B.H., Unutzer, J., Mood symptoms, functional impairment and disability in people with bipolar disorder: specific effects of mania and depression. J. Clin. Psychiatry 68:8 (2007), 1237–1245.
70. Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14–4863. 2014, Substance Abuse and mental Health Services Administration, Rockville, MD.
71. ten Have, M., Vollebergh, W., Bijl, R., Nolen, W.A., Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilization): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). J. Affect. Disord. 68:2–3 (2002), 203–213.
72. Tijssen, M.J., Van Os, J., Wittchen, H.-U., et al. Evidence that bipolar disorder is the poor outcome fraction of a common developmental phenotype: an 8-year cohort study in young people. Psychol. Med. 40:2 (2010), 289–299.
73. Vallarino, M., Henry, C., Etain, B., et al. An evidence map of psychosocial interventions for the earliest stages of bipolar disorder. Lancet Psychiatry 2:6 (2015), 548–563.
74. Vancampfort, D., Vansteelandt, K., Correll, C.U., et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am. J. Psychiatry 170:3 (2013), 265–274.
75. Weber, N.S., Fisher, J.A., Cowan, D.N., Niebuhr, D.W., Psychiatric and general medical conditions comorbid with bipolar disorder in the National Hospital Discharge Survey. Psychiatry Serv. 62:10 (2011), 1152–1158.
76. Weissman, M.M., Bland, R.C., Canino, G.J., et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276:4 (1996), 293–299.
77. Westman, J., Hallgren, J., Wahlbeck, K., et al. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open, 3(4), 2013.
78. Xiong Lai, H.M., Cleary, M., Sitharthan, T., Hunt, G.E., Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: a system review and meta-analysis. Drug Alcohol Depend. 154:1 (2015), 1–13.
79. Xu, Y., Okuda, M., Hser, Y.I., et al. Twelve-month prevalence of psychiatric disorders and treatment-seeking among asian Americans/pacific Islanders in the United States: results from the national epidemiological survey on alcohol and related conditions. J. Psychiatry Res. 45:7 (2011), 910–918.
80. Yoon, Y.-H., Chen, C.M., Yi, H.Y., Moss, H.B., Effect of comorbid alcohol and drug use disorders on premature death among unipolar and bipolar disorder decedents in the United States, 1999 to 2006. Compr. Psychiatry 52:4 (2011), 453–464.
81. Zimmerman, M., Ruggero, C.J., Chelminski, I., et al. Is bipolar disorder overdiagnosed?. J. Clin. Psychiatry 69:6 (2008), 935–940.